Associations of childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk factors in adolescence: Prospective findings from the Avon Longitudinal Study of Parents and Children

European Journal of Preventive Cardiology

Volumn 21, Issue 3, 2014, Pages 281-290

  Williams, Dylan M ^a   Fraser, Abigail ^a   Sayers, Adrian ^a   Fraser, William D ^b   Hyppönen, Elina ^c   Smith, George Davey ^a   Sattar, Naveed ^d   Lawlor, Debbie A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

ALSPAC; cardiovascular diseases; paediatrics; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL; C REACTIVE PROTEIN; CALCIFEDIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADOLESCENT HEALTH; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHILD HEALTH; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ALSPAC; CARDIOVASCULAR DISEASES; PAEDIATRICS; VITAMIN D;

25-HYDROXYVITAMIN D 2; ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; CALCIFEDIOL; CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL, HDL; ENGLAND; FEMALE; HUMANS; INSULIN; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VITAMIN D DEFICIENCY;

EID: 84896728820     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/2047487312465688     Document Type: Article

References (39)

1. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 ; 168: 1340-1349
2. Forouhi NG, Luan Ja, Cooper A, et al. Baseline serum 25-hydroxy vitamin D Is predictive of future glycemic status and insulin resistance. Diabetes. 2008 ; 57: 2619-2625
3. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007 ; 49: 1063-1069
4. Williams DM, Fraser A, Lawlor DA. Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents. Heart. 2011 ; 97: 315-320
5. Ford ES, Zhao G, Tsai J, et al. Associations between concentrations of vitamin D and concentrations of insulin, glucose, and HbA1c among adolescents in the United States. Diabetes Care. 2011 ; 34: 646-648
6. Johnson MD, Nader NS, Weaver AL, et al. Relationships between 25-hydroxyvitamin D levels and plasma glucose and lipid levels in pediatric outpatients. J Pediatr. 2010 ; 156: 444-449
7. Rajakumar K, de las Heras J, Chen TC, et al. Vitamin D status, adiposity, and lipids in Black American and Caucasian children. J Clin Endocrinol Metab. 2011 ; 96: 1560-1567
8. Kelly A, Brooks LJ, Dougherty S, et al. A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child. 2011 ; 96: 447-452
9. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D-2) as a vitamin supplement. Am J Clin Nutr. 2006 ; 84: 694-697
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 ; 96: 1911-1930
11. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011; CD007470.
12. Judd SE and Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 2009; 338: 40 - 44.
13. Williams DM, Fraser A, Sayers A, et al. Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: Cross-sectional findings from the Avon Longitudinal Study of Parents and Children. J Clin Endocrinol Metab 2012; 97(5): 1563 - 1571.
14. Fraser A, Williams D, Lawlor DA. Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: Analysis of 3 NHANES cycles (2001-2006). PLoS ONE. 2010 ; 5: e13882 - e13882
15. Boyd A, Golding J, Macleod J, et al. Cohort profile: The 'Children of the 90s' - the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol 2012; 41(5): 1 - 17.
16. Fraser A, Macdonald-Wallis C, Tilling K, et al. Cohort Profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol 2012; 41(5): 1 - 14.
17. Hagstrom E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009 ; 119: 2765-2771
18. Lind L, Skarfors E, Berglund L, et al. Serum calcium: A new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol. 1997 ; 50: 967-973
19. Foley RN. Phosphate levels and cardiovascular disease in the general population. Clin J Am Soc Nephrol. 2009 ; 4: 1136-1139
20. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: The Tromsø Study. Eur J Cardiovasc Prevent Rehabil. 2004 ; 11: 69-74
21. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999 ; 28: 964-974
22. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 ; 357: 266-281
23. Lavie CJ, Lee JH, Milani RV. Vitamin D and cardiovascular disease: Will it live up to its hype?. J Am Coll Cardiol. 2011 ; 58: 1547-1556
24. Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007 ; 115: 846-854
25. Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001 ; 86: 1633-1637
26. Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2011 ; 96: 1931-1942
27. Wong KE, Szeto FL, Zhang W, et al. Involvement of the vitamin D receptor in energy metabolism: Regulation of uncoupling proteins. Am J Physiol Endocrinol Metab. 2009 ; 296: E820 - E828
28. Wang J-H, Keisala T, Solakivi T, et al. Serum cholesterol and expression of ApoAI, LXRβ and SREBP2 in vitamin D receptor knock-out mice. J Steroid Biochem Mol Biol. 2009 ; 113: 222-226
29. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res. 2011 ; 50: 303-312
30. Mattila C, Knekt P, Mannisto S, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007 ; 30: 2569-2570
31. Maestro B, Campion J, Davila N, et al. Stimulation by 1,25-dihydroxyvitamin D-3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000 ; 47: 383-391
32. Dunlop TW, Väisänen S, Frank C, et al. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol. 2005 ; 349: 248-260
33. Mitri J, Dawson-Hughes B, Hu FB, et al. Effects of vitamin D and calcium supplementation on pancreatic ß cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011 ; 94: 486-494
34. Pacifico L, Anania C, Osborn JF, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 2011; 165: 603 - 611.
35. Hofmann JN, Yu K, Horst RL, et al. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev. 2010 ; 19: 927-931
36. Holick MF. Vitamin D deficiency in 2010: Health benefits of vitamin D and sunlight: A D-bate. Nat Rev Endocrinol. 2011 ; 7: 73-75
37. O'Keefe JH, Lavie CJ, Holick MF. Vitamin D supplementation for cardiovascular disease prevention. JAMA. 2011 ; 306: 1546-1547
38. Shapses SA, Manson JE. Vitamin D and prevention of cardiovascular disease and diabetes. JAMA. 2011 ; 305: 2565-2566
39. Ross AC. The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr. 2011 ; 14: 938-939